Overview

Dose-Response of Gonadal Steroids and Bone Turnover in Older Men

Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the levels of testosterone and/or estradiol at which changes in bone turnover, body composition, strength, sexual function etc. begin to occur in older men. This information may help determine when to intervene with hormone replacement therapy in aging men.
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
AbbVie
AstraZeneca
National Institute on Aging (NIA)
Solvay Pharmaceuticals
Treatments:
Anastrozole
Goserelin
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate